IP Library Granted Patent US 7,875,591
Granted Patent B2
US 7,875,591 · App. 12/428,031 · Granted Jan 25, 2011

Delivery system for heparin-binding growth factors

Assignee: University of Delaware
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,875,591
App. No.
12/428,031
Granted
Jan 25, 2011
Kind
B2
Abstract

A device comprising a scaffold coated with a protein having at least 83% identity to the amino acid sequence of the core protein of domain I of a mammalian perlecan, wherein at least one glycosaminoglycan is attached to the protein is described. The device may be used in vitro or in vivo to induce replication and/or differentiation of connective tissue cells and to repair tissue.

Claims (19)

1. An implantable device comprising a scaffold, the scaffold coated with a proteoglycan that consists of an amino acid sequence having at least 84% homology to the amino acid sequence of the core protein of domain I of a mammalian perlecan, wherein the proteoglycan has at least one heparan sulfate glycosaminoglycan chain attached, and wherein the proteoglycan stimulates mesenchymal stem cell differentiation to cartilage.

2. The device of claim 1 , further comprising at least one growth factor attached to the glycosaminoglycan chain.

3. The device of claim 2 , wherein the growth factor is a heparin-binding growth factor.

4. The device of claim 1 , wherein the device is a medical device.

5. The device of claim 1 , wherein the scaffold comprises a polymer, biologically derived material, ceramic, metal, or combinations thereof.

6. The device of claim 1 , wherein the device is implanted in a mammal.

7. The device of claim 2 , wherein the growth factor induces differentiation of connective tissue cells.

8. The device of claim 7 , wherein the connective tissue cells are chondrocytes or fibroblasts.

9. The device of claim 1 , wherein the proteoglycan has two or three glycosaminoglycan chains attached.

10. A device for producing connective tissue cells for the repair of tissues or organs comprising a scaffold coated with a proteoglycan that consists of an amino acid sequence having at least 84% homology to the amino acid sequence of the core protein of domain I of a mammalian perlecan, wherein the proteoglycan has at least one heparan sulfate glycosaminoglycan chain attached, wherein the proteoglycan stimulates mesenchymal stem cell differentiation to cartilage, and wherein at least one growth factor capable of inducing connective tissue cells to replicate or to differentiate is attached to the glycosaminoglycan chain.

11. The device of claim 10 , wherein the growth factor is a heparin-binding growth factor.

12. The device of claim 10 , wherein the scaffold comprises a polymer, biologically derived material, ceramic, metal, or combinations thereof.

13. The device of claim 10 , wherein the cells are connective tissue cells.

14. The device of claim 13 , wherein the connective tissue cells are chondrocytes or fibroblasts.

15. The device of claim 10 , wherein the proteoglycan has two or three glycosaminoglycan chains attached to the protein.

16. The device of claim 1 , wherein the protein has at least 84% homology to the amino acid sequence of SEQ ID NO: 1.

17. The device of claim 1 , wherein the protein consists of the amino acid sequence of SEQ ID NO: 1.

18. The device of claim 1 , wherein the protein has at least 84% homology to the amino acid sequence of SEQ ID NO: 2.

19. The device of claim 1 , wherein the protein consists of the amino acid sequence of SEQ ID NO: 2.

Assignments (1)
CONFIRMATORY LICENSE Recorded Nov 4, 2021
From: UNIVERSITY OF DELAWARE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 058024/0740 →
Continuity (3)
Division 1036336800
Provisional Application 6022893500 · Aug 30, 2000
Related Publication 20100221302A1 · Sep 2, 2010